메뉴 건너뛰기




Volumn 24, Issue 1, 2007, Pages 39-41

Menorrhagia and minor bleeding symptoms in women on oral anticoagulation

Author keywords

Menorrhagia; Minor bleeding symptoms; Oral anticoagulation; Warfarin

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; CLOPIDOGREL; LEVONORGESTREL; ORAL CONTRACEPTIVE AGENT; TRANEXAMIC ACID;

EID: 34249679559     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11239-006-0003-7     Document Type: Article
Times cited : (48)

References (7)
  • 1
    • 0033546572 scopus 로고    scopus 로고
    • Anticoagulant therapy can be safer: An active follow-up and written care programs reduce the number of complications
    • [in Swedish]
    • Johansson H (1999) Anticoagulant therapy can be safer: An active follow-up and written care programs reduce the number of complications [in Swedish]. Läkartidningen 96:3388-3390
    • (1999) Läkartidningen , vol.96 , pp. 3388-3390
    • Johansson, H.1
  • 3
    • 0242351842 scopus 로고    scopus 로고
    • Risk of hemorrhagic stroke in patients with oral anticoagulation compared to the general population
    • Själander A, Engström G, Berntorp E, Svensson P (2003) Risk of hemorrhagic stroke in patients with oral anticoagulation compared to the general population. J Intern Med 254:434-438
    • (2003) J Intern Med , vol.254 , pp. 434-438
    • Själander, A.1    Engström, G.2    Berntorp, E.3    Svensson, P.4
  • 4
    • 0025336461 scopus 로고
    • Measured menstrual blood loss in women with a bleeding disorder using oral anticoagulant therapy
    • van Eijkeren M, Christiaens G, Haspels A, Sixma J (1990) Measured menstrual blood loss in women with a bleeding disorder using oral anticoagulant therapy. Am J Obstet Gynecol 62:1261-1263
    • (1990) Am J Obstet Gynecol , vol.62 , pp. 1261-1263
    • van Eijkeren, M.1    Christiaens, G.2    Haspels, A.3    Sixma, J.4
  • 5
    • 0345414673 scopus 로고    scopus 로고
    • SPORTIF III investigators stroke prevention with the oral direct thrombin inhibitor ximegalatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): Randomized controlled trial
    • Olsson BS et al (2003) SPORTIF III investigators stroke prevention with the oral direct thrombin inhibitor ximegalatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomized controlled trial. Lancet 362:1691-1698
    • (2003) Lancet , vol.362 , pp. 1691-1698
    • Olsson, B.S.1
  • 6
    • 0041829444 scopus 로고    scopus 로고
    • Oral ximegalatran for secondary prophylaxis after myocardial infarction: The ESTEEM randomized controlled trial
    • Wallentin L, Wilcox RG, Weaver WD, Emanuelsson H, Goodvin A, Nystrom P, Bylock A (2003) Oral ximegalatran for secondary prophylaxis after myocardial infarction: The ESTEEM randomized controlled trial. Lancet 362:789-797
    • (2003) Lancet , vol.362 , pp. 789-797
    • Wallentin, L.1    Wilcox, R.G.2    Weaver, W.D.3    Emanuelsson, H.4    Goodvin, A.5    Nystrom, P.6    Bylock, A.7
  • 7
    • 0142182558 scopus 로고    scopus 로고
    • Secondary prevention of venous thromboembolism with the oral direct thrombin inhibitor ximegalatran
    • THRIVE III Investigators
    • Schulman S, Wahlander K, Lundstrom T, Clason SB, Eriksson H (2003) THRIVE III Investigators. Secondary prevention of venous thromboembolism with the oral direct thrombin inhibitor ximegalatran. N Eng J Med 349:1713-1721
    • (2003) N Eng J Med , vol.349 , pp. 1713-1721
    • Schulman, S.1    Wahlander, K.2    Lundstrom, T.3    Clason, S.B.4    Eriksson, H.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.